Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

BCLIBCLI
4 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in BrainStorm Cell Therapeutics In

WELLS FARGO & COMPANY/MN previously held 0 shares of BCLI (BrainStorm Cell Therapeutics In), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$3,037

Total Shares Change

-1,338

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$0.70
0
2025-Q2
Unchanged
1,338
0.0%
$1,4990.0%$1.06
0
2025-Q1
Unchanged
1,338
0.0%
$1,6860.0%$1.19
0
2024-Q4
New
1,338
-
$3,0370.0%$2.37
20

Other major holders of BCLI: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used